Maggot debridement therapy as primary tool to treat chronic wound of animals

Vijayata Choudhary1, Mukesh Choudhary2, Sunanda Pandey2

  • 1Department of Veterinary Parasitology, Veterinary College, Anand Agricultural University, Anand, Gujarat, India.

Veterinary World
|May 17, 2016
PubMed

Insights

Maggot debridement therapy (MDT) uses sterile maggots to treat chronic wounds in animals. This review explores its potential as a veterinary treatment, especially with rising antibiotic resistance.

Area of Science:

  • Veterinary Medicine
  • Wound Healing
  • Medical Entomology

Background:

  • Chronic wound infections and antibiotic resistance pose challenges in veterinary medicine.
  • Maggot debridement therapy (MDT) is an established treatment for human chronic wounds.
  • The application of MDT in veterinary medicine is limited but shows promise.

Purpose of the Study:

  • To review existing literature on maggot therapy for animal wound treatment.
  • To establish a theoretical foundation for the clinical use of MDT in veterinary medicine.
  • To explore MDT as an alternative to amputation or euthanasia for non-healing animal wounds.

Main Methods:

  • Literature review of studies on maggot therapy in animals.
  • Analysis of the efficacy and safety of Lucilia (Phaenicia) sericata maggots.
  • Discussion of MDT's role in managing chronic wounds in veterinary patients.

Main Results:

  • Maggots (Lucilia (Phaenicia) sericata) selectively debride necrotic tissue.
  • MDT offers a safe and effective method for wound debridement and disinfection.
  • Limited clinical studies exist, but MDT has potential in veterinary applications.

Conclusions:

  • Maggot debridement therapy presents a viable treatment option for non-healing animal wounds.
  • Increased antibiotic resistance may drive the adoption of MDT in veterinary practice.
  • Further clinical research is needed to fully establish MDT in animal care.